312 related articles for article (PubMed ID: 22115706)
1. Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer.
Raz G; Allen KE; Kingsley C; Cherni I; Arora S; Watanabe A; Lorenzo CD; Edwards V DK; Sridhar S; Hostetter G; Weiss GJ
Lung Cancer; 2012 May; 76(2):191-6. PubMed ID: 22115706
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas.
Gialmanidis IP; Bravou V; Amanetopoulou SG; Varakis J; Kourea H; Papadaki H
Lung Cancer; 2009 Oct; 66(1):64-74. PubMed ID: 19200615
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor-related tumor markers and clinical outcomes with erlotinib in non-small cell lung cancer: an analysis of patients from german centers in the TRUST study.
Schneider CP; Heigener D; Schott-von-Römer K; Gütz S; Laack E; Digel W; Guschall WR; Franke A; Bodenstein H; Schmidtgen C; Reck M
J Thorac Oncol; 2008 Dec; 3(12):1446-53. PubMed ID: 19057271
[TBL] [Abstract][Full Text] [Related]
4. STAT3 activation and aberrant ligand-dependent sonic hedgehog signaling in human pulmonary adenocarcinoma.
Yang Q; Shen SS; Zhou S; Ni J; Chen D; Wang G; Li Y
Exp Mol Pathol; 2012 Oct; 93(2):227-36. PubMed ID: 22554932
[TBL] [Abstract][Full Text] [Related]
5. Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer.
Brugger W; Triller N; Blasinska-Morawiec M; Curescu S; Sakalauskas R; Manikhas GM; Mazieres J; Whittom R; Ward C; Mayne K; Trunzer K; Cappuzzo F
J Clin Oncol; 2011 Nov; 29(31):4113-20. PubMed ID: 21969500
[TBL] [Abstract][Full Text] [Related]
6. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of the expression of Hedgehog proteins in cervical carcinoma FIGO stages I-IV treated with radiotherapy or chemoradiotherapy.
Bohr Mordhorst L; Ahlin C; Sorbe B
Gynecol Oncol; 2014 Nov; 135(2):305-11. PubMed ID: 25158038
[TBL] [Abstract][Full Text] [Related]
8. The effects of sonic hedgehog signaling pathway components on non-small-cell lung cancer progression and clinical outcome.
Hwang J; Kang MH; Yoo YA; Quan YH; Kim HK; Oh SC; Choi YH
World J Surg Oncol; 2014 Aug; 12():268. PubMed ID: 25141859
[TBL] [Abstract][Full Text] [Related]
9. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
10. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL
Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and activation of epidermal growth factor receptor 1 (EGFR1), ERK, AKT, STAT3, and TWIST1 in nonsmall cell lung cancer (NSCLC).
Gorgisen G; Ozes D; Pehlivanoglu S; Erdogan A; Dertsiz L; Ozbilim G; Ozbudak IH; Savas B; Ozes ON
Exp Lung Res; 2013 Nov; 39(9):387-98. PubMed ID: 24117170
[TBL] [Abstract][Full Text] [Related]
12. High expression of Sonic hedgehog signaling proteins is related to the favorable outcome, EGFR mutation, and lepidic predominant subtype in primary lung adenocarcinoma.
Kim JE; Kim H; Choe JY; Sun P; Jheon S; Chung JH
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S570-6. PubMed ID: 23709101
[TBL] [Abstract][Full Text] [Related]
13. High expression of truncated GLI3 is associated with poor overall survival in patients with non-small cell lung cancer.
Bai XY; Lin JY; Zhang XC; Xie Z; Yan HH; Chen ZH; Xu CR; An SJ; Sheng GM; Wu YL
Cancer Biomark; 2013; 13(1):37-47. PubMed ID: 23736020
[TBL] [Abstract][Full Text] [Related]
14. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
15. Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Carcinoma.
Giroux Leprieur E; Vieira T; Antoine M; Rozensztajn N; Rabbe N; Ruppert AM; Lavole A; Cadranel J; Wislez M
Clin Lung Cancer; 2016 Jul; 17(4):301-8. PubMed ID: 26762562
[TBL] [Abstract][Full Text] [Related]
16. Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer.
Khambata-Ford S; Harbison CT; Hart LL; Awad M; Xu LA; Horak CE; Dakhil S; Hermann RC; Lynch TJ; Weber MR
J Clin Oncol; 2010 Feb; 28(6):918-27. PubMed ID: 20100958
[TBL] [Abstract][Full Text] [Related]
17. Impact of epidermal growth factor receptor and KRAS mutations on clinical outcome in resected non-small cell lung cancer patients.
Ragusa M; Vannucci J; Ludovini V; Bianconi F; Treggiari S; Tofanetti FR; Flacco A; Colella R; Sidoni A; Crinò L; Puma F
Am J Clin Oncol; 2014 Aug; 37(4):343-9. PubMed ID: 23357969
[TBL] [Abstract][Full Text] [Related]
18. Sonic hedgehog pathway dysregulation in skin basal-cell carcinoma of a Polish population.
Lesiak A; Sobolewska-Sztychny D; Danilewicz M; Rogowski-Tylman M; Sysa-Jedrzejowska A; Sobjanek M; Olejniczak-Staruch I; Narbutt J
Folia Histochem Cytobiol; 2013; 51(3):219-24. PubMed ID: 24203628
[TBL] [Abstract][Full Text] [Related]
19. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
[TBL] [Abstract][Full Text] [Related]
20. Expression of SHH signaling pathway components in the developing human lung.
Zhang M; Wang H; Teng H; Shi J; Zhang Y
Histochem Cell Biol; 2010 Oct; 134(4):327-35. PubMed ID: 20821230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]